Cara Therapeutics, Inc. (CARA)
USD 4.52
(-5.8%)
USD 4.52
(-5.8%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -118.51 Million USD | -42.08% |
| 2022 | -83.41 Million USD | 5.42% |
| 2021 | -88.19 Million USD | -1148.67% |
| 2020 | 8.41 Million USD | 107.91% |
| 2019 | -106.37 Million USD | -43.72% |
| 2018 | -74.01 Million USD | -27.33% |
| 2017 | -58.12 Million USD | -1.48% |
| 2016 | -57.28 Million USD | -132.0% |
| 2015 | -24.69 Million USD | -39.14% |
| 2014 | -17.74 Million USD | -347.77% |
| 2013 | -3.96 Million USD | 36.8% |
| 2012 | -6.27 Million USD | 36.05% |
| 2011 | -9.8 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -20.01 Million USD | 34.79% |
| 2024 Q1 | -30.69 Million USD | 5.07% |
| 2023 Q3 | -28.03 Million USD | 10.95% |
| 2023 FY | -118.51 Million USD | -42.08% |
| 2023 Q4 | -32.33 Million USD | -15.36% |
| 2023 Q1 | -25.68 Million USD | 12.57% |
| 2023 Q2 | -31.47 Million USD | -22.58% |
| 2022 Q4 | -29.37 Million USD | -30.45% |
| 2022 Q2 | -3.94 Million USD | 85.72% |
| 2022 Q1 | -27.58 Million USD | 17.36% |
| 2022 Q3 | -22.51 Million USD | -471.45% |
| 2022 FY | -83.41 Million USD | 5.42% |
| 2021 Q3 | -1.01 Million USD | 96.71% |
| 2021 Q1 | -23.3 Million USD | -129.53% |
| 2021 Q2 | -30.74 Million USD | -31.95% |
| 2021 Q4 | -33.38 Million USD | -3195.36% |
| 2021 FY | -88.19 Million USD | -1148.67% |
| 2020 Q4 | 78.9 Million USD | 577.98% |
| 2020 FY | 8.41 Million USD | 107.91% |
| 2020 Q1 | -28.92 Million USD | -1.09% |
| 2020 Q2 | -25.06 Million USD | 13.33% |
| 2020 Q3 | -16.5 Million USD | 34.14% |
| 2019 Q3 | -32.84 Million USD | -43.04% |
| 2019 Q1 | -21.96 Million USD | -6.33% |
| 2019 FY | -106.37 Million USD | -43.72% |
| 2019 Q4 | -28.61 Million USD | 12.88% |
| 2019 Q2 | -22.96 Million USD | -4.55% |
| 2018 Q2 | -17.19 Million USD | -2.55% |
| 2018 FY | -74.01 Million USD | -27.33% |
| 2018 Q1 | -16.76 Million USD | -18.27% |
| 2018 Q3 | -19.4 Million USD | -12.83% |
| 2018 Q4 | -20.65 Million USD | -6.45% |
| 2017 Q1 | -22.2 Million USD | -1.06% |
| 2017 Q3 | -12.44 Million USD | -33.81% |
| 2017 Q4 | -14.17 Million USD | -13.93% |
| 2017 FY | -58.12 Million USD | -1.48% |
| 2017 Q2 | -9.3 Million USD | 58.12% |
| 2016 Q2 | -13.07 Million USD | -22.29% |
| 2016 Q1 | -10.69 Million USD | -12.19% |
| 2016 Q4 | -21.97 Million USD | -90.36% |
| 2016 Q3 | -11.54 Million USD | 11.72% |
| 2016 FY | -57.28 Million USD | -132.0% |
| 2015 FY | -24.69 Million USD | -39.14% |
| 2015 Q4 | -9.53 Million USD | -99.08% |
| 2015 Q3 | -4.78 Million USD | 15.78% |
| 2015 Q2 | -5.68 Million USD | -21.22% |
| 2015 Q1 | -4.68 Million USD | -12.39% |
| 2014 Q1 | -3.38 Million USD | -61.63% |
| 2014 FY | -17.74 Million USD | -347.77% |
| 2014 Q4 | -4.17 Million USD | 36.26% |
| 2014 Q3 | -6.54 Million USD | -79.56% |
| 2014 Q2 | -3.64 Million USD | -7.74% |
| 2013 Q2 | 5.33 Million USD | 302.77% |
| 2013 Q3 | -4.57 Million USD | -185.72% |
| 2013 Q1 | -2.63 Million USD | -46.47% |
| 2013 Q4 | -2.09 Million USD | 54.25% |
| 2013 FY | -3.96 Million USD | 36.8% |
| 2012 Q3 | -1.16 Million USD | 0.0% |
| 2012 FY | -6.27 Million USD | 36.05% |
| 2012 Q4 | -1.79 Million USD | -53.85% |
| 2011 FY | -9.8 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -146.39 Million USD | 19.047% |
| Alkermes plc | 355.75 Million USD | 133.313% |
| Agenus Inc. | -245.76 Million USD | 51.777% |
| Aptorum Group Limited | -2.82 Million USD | -4095.675% |
| Ardelyx, Inc. | -66.06 Million USD | -79.383% |
| Dyadic International, Inc. | -6.79 Million USD | -1644.002% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -12561.645% |
| Lantern Pharma Inc. | -15.96 Million USD | -642.491% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -522.806% |
| Novavax, Inc. | -545.06 Million USD | 78.257% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -103.306% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -60.608% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -539.019% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -1086.792% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -100.929% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | 68.281% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -386.92% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -217.389% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | 27.988% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -61.579% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -484.067% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -90.367% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -264.824% |
| C4 Therapeutics, Inc. | -132.49 Million USD | 10.552% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | 73.08% |
| AlloVir, Inc. | -190.41 Million USD | 37.762% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | 42.266% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -316.537% |
| Bicycle Therapeutics plc | -180.66 Million USD | 34.401% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | 33.811% |
| ChromaDex Corporation | -4.93 Million USD | -2300.02% |
| Chimerix, Inc. | -82.09 Million USD | -44.361% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -165.704% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -16.11% |
| CRISPR Therapeutics AG | -153.61 Million USD | 22.848% |
| Precision BioSciences, Inc. | -61.31 Million USD | -93.273% |
| Fate Therapeutics, Inc. | -160.92 Million USD | 26.357% |
| Fortress Biotech, Inc. | -60.63 Million USD | -95.447% |
| Fortress Biotech, Inc. | -60.63 Million USD | -95.447% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -45.272% |
| ImmuCell Corporation | -5.77 Million USD | -1952.316% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -4.915% |
| Immix Biopharma, Inc. | -15.42 Million USD | -668.265% |
| Incyte Corporation | 597.59 Million USD | 119.832% |
| Innoviva, Inc. | 179.72 Million USD | 165.942% |
| IO Biotech, Inc. | -86.08 Million USD | -37.673% |
| Jaguar Health, Inc. | -41.3 Million USD | -186.956% |
| Keros Therapeutics, Inc. | -152.99 Million USD | 22.536% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 327.237% |
| ContextLogic Inc. | -317 Million USD | 62.614% |
| MiMedx Group, Inc. | 67.43 Million USD | 275.734% |
| MEI Pharma, Inc. | 17.77 Million USD | 766.627% |
| NextCure, Inc. | -62.72 Million USD | -88.947% |
| Onconetix, Inc. | -37.4 Million USD | -216.798% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -200.193% |
| Opthea Limited | -220.24 Million USD | 46.19% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -131.656% |
| Vaxcyte, Inc. | -402.26 Million USD | 70.539% |
| PDS Biotechnology Corporation | -42.94 Million USD | -175.983% |
| Precigen, Inc. | -95.9 Million USD | -23.575% |
| Pharming Group N.V. | -10.54 Million USD | -1023.559% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | 41.211% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -382.879% |
| PureTech Health plc | -65.69 Million USD | -80.393% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -372.333% |
| Avidity Biosciences, Inc. | -212.22 Million USD | 44.156% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -386.92% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | 54.035% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -335.102% |
| Acelyrin, Inc. | -381.64 Million USD | 68.946% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -944777.056% |
| Summit Therapeutics Inc. | -614.92 Million USD | 80.727% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -247.535% |
| Senti Biosciences, Inc. | -92.91 Million USD | -27.544% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -13.194% |
| Elevation Oncology, Inc. | -45.7 Million USD | -159.306% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -237.26% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -806.627% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -1672.82% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -303.627% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -1294.107% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -106.063% |
| Seer, Inc. | -86.27 Million USD | -37.363% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -76.898% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -80.207% |
| ESSA Pharma Inc. | -26.58 Million USD | -345.834% |
| GlycoMimetics, Inc. | -36.89 Million USD | -221.178% |
| GT Biopharma, Inc. | -7.59 Million USD | -1459.997% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | 50.898% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -128.239% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 265.961% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -117.767% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -141.272% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -1091.355% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 79.311% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -3203.038% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -132.114% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | 51.745% |
| Aptose Biosciences Inc. | -51.2 Million USD | -131.439% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -20.565% |
| Soligenix, Inc. | -6.14 Million USD | -1829.95% |
| Century Therapeutics, Inc. | -136.67 Million USD | 13.287% |
| Kura Oncology, Inc. | -152.63 Million USD | 22.353% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -32.835% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -1024.625% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 21058.318% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -20728.295% |
| Autolus Therapeutics plc | -208.38 Million USD | 43.127% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -64.835% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -67.403% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -446.949% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | 47.386% |
| GRI Bio, Inc. | -13.03 Million USD | -809.051% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -2766.387% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | 4.49% |
| IGM Biosciences, Inc. | -246.41 Million USD | 51.905% |
| INmune Bio, Inc. | -30 Million USD | -294.938% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -7.194% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -180.878% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -642.486% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -650.321% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -98.564% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -17.146% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | 57.08% |
| Coherus BioSciences, Inc. | -237.89 Million USD | 50.182% |
| Verastem, Inc. | -87.36 Million USD | -35.65% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -118.707% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | 26.543% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -1.59% |
| Histogen Inc. | -10.62 Million USD | -1015.837% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -729.531% |
| Surrozen, Inc. | -43.04 Million USD | -175.343% |
| Organovo Holdings, Inc. | -14.67 Million USD | -707.805% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -2229.71% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -126.434% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -369.117% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -339.947% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -1318.114% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | 21.559% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -142.229% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -298.698% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -1037.612% |
| Apollomics, Inc. | -172.6 Million USD | 31.337% |
| Amarin Corporation plc | -59.11 Million USD | -100.489% |
| Mesoblast Limited | -87.95 Million USD | -34.741% |
| Turnstone Biologics Corp. | -55.2 Million USD | -114.697% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | 19.358% |
| Synaptogenix, Inc. | -6.03 Million USD | -1862.622% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -631.201% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -51.901% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -2373.418% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -1310.5% |
| Exelixis, Inc. | 207.76 Million USD | 157.042% |
| Better Therapeutics, Inc. | -39.76 Million USD | -198.071% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | 17.67% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 77.581% |
| NLS Pharmaceutics AG | -12.17 Million USD | -873.65% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -1420.432% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -285.421% |
| Gritstone bio, Inc. | -138.49 Million USD | 14.425% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -83.841% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -2862.862% |
| Avid Bioservices, Inc. | -140.75 Million USD | 15.801% |
| Insmed Incorporated | -749.56 Million USD | 84.189% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -680.229% |
| MediWound Ltd. | -6.71 Million USD | -1664.637% |
| OmniAb, Inc. | -50.61 Million USD | -134.128% |
| Alector, Inc. | -130.39 Million USD | 9.11% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -4.211% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -128.582% |
| Zai Lab Limited | -334.62 Million USD | 64.583% |
| Revance Therapeutics, Inc. | -323.98 Million USD | 63.42% |
| Aura Biosciences, Inc. | -76.4 Million USD | -55.105% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | 49.49% |
| Immunic, Inc. | -93.61 Million USD | -26.6% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | 12.789% |
| Veracyte, Inc. | -74.4 Million USD | -59.283% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -1444.033% |
| FibroGen, Inc. | -284.23 Million USD | 58.304% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -351.788% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -1592.586% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -529.294% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 128.569% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -425.44% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 340.533% |
| TG Therapeutics, Inc. | 12.67 Million USD | 1035.235% |
| Galecto, Inc. | -38.34 Million USD | -209.038% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -528.183% |
| Fortrea Holdings Inc. | -3.4 Million USD | -3385.676% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | 6.42% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -580.679% |
| XBiotech Inc. | -24.55 Million USD | -382.604% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -83.841% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -89.076% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -20.408% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -453.101% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -114.725% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 80.464% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -73.633% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -208058.57% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | 47.685% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -432.224% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | 46.059% |
| NexImmune, Inc. | -32.34 Million USD | -266.41% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -2141.773% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -743.755% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 102.998% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -389.299% |
| Scopus BioPharma Inc. | -11.6 Million USD | -920.799% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -1.468% |
| Ainos, Inc. | -13.77 Million USD | -760.627% |
| Pluri Inc. | -20.88 Million USD | -467.374% |
| Prothena Corporation plc | -147.02 Million USD | 19.394% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -4.077% |
| Celularity Inc. | -196.29 Million USD | 39.625% |
| Rallybio Corporation | -74.56 Million USD | -58.941% |
| Cue Biopharma, Inc. | -50.73 Million USD | -133.601% |
| MeiraGTx Holdings plc | -84.02 Million USD | -41.042% |
| Omeros Corporation | -117.81 Million USD | -0.594% |
| Humacyte, Inc. | -110.77 Million USD | -6.984% |
| Immunocore Holdings plc | -55.28 Million USD | -114.36% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -558.991% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -416.824% |
| Blueprint Medicines Corporation | -506.98 Million USD | 76.624% |
| CalciMedica, Inc. | -34.35 Million USD | -244.946% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -75.121% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | 16.189% |
| Scholar Rock Holding Corporation | -165.78 Million USD | 28.516% |
| Sana Biotechnology, Inc. | -283.25 Million USD | 58.16% |
| Pulmatrix, Inc. | -14.12 Million USD | -739.268% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -236.732% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -43.412% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | 75.371% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -13.008% |
| Cytokinetics, Incorporated | -526.24 Million USD | 77.479% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -228.609% |
| Nutriband Inc. | -5.48 Million USD | -2060.551% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -193.204% |
| Vor Biopharma Inc. | -117.86 Million USD | -0.551% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 102.725% |
| Evogene Ltd. | -23.87 Million USD | -396.306% |
| ProKidney Corp. | -35.46 Million USD | -234.141% |
| Applied Therapeutics, Inc. | -119.76 Million USD | 1.044% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -1410.607% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 81.575% |
| CorMedix Inc. | -46.33 Million USD | -155.751% |
| BioLineRx Ltd. | -60.61 Million USD | -95.521% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -16.482% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -188.592% |
| Atai Life Sciences N.V. | -40.22 Million USD | -194.633% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -46.947% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -56.927% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | 59.44% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -325.143% |
| MediciNova, Inc. | -8.57 Million USD | -1282.638% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | 3.864% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -1314.771% |
| GeoVax Labs, Inc. | -25.96 Million USD | -356.403% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | 50.462% |
| Biomea Fusion, Inc. | -117.25 Million USD | -1.073% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 81.086% |
| Mereo BioPharma Group plc | -29.46 Million USD | -302.203% |
| Cullinan Oncology, Inc. | -153.16 Million USD | 22.622% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | 43.393% |
| Absci Corporation | -110.56 Million USD | -7.188% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -293.078% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -17.529% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | 49.769% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 941.473% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | 38.582% |
| Allakos Inc. | -185.7 Million USD | 36.181% |
| Imunon, Inc. | -19.51 Million USD | -507.293% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -21.758% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 211.657% |
| BioAtla, Inc. | -123.46 Million USD | 4.009% |
| NLS Pharmaceutics AG | -12.17 Million USD | -873.65% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -637.113% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | 63.787% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -220.748% |
| XOMA Corporation | -40.83 Million USD | -190.253% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -16.337% |
| aTyr Pharma, Inc. | -50.38 Million USD | -135.196% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -35.167% |
| Akero Therapeutics, Inc. | -151.75 Million USD | 21.907% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | 50.149% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -237.461% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -1364.581% |
| Akari Therapeutics, Plc | -10 Million USD | -1084.183% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -175931.192% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 142.086% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -1678.166% |
| UroGen Pharma Ltd. | -102.24 Million USD | -15.912% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -10.975% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -1423.855% |
| Orgenesis Inc. | -55.36 Million USD | -114.073% |
| Entera Bio Ltd. | -8.88 Million USD | -1233.255% |
| GH Research PLC | -35.58 Million USD | -233.023% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -468.68% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -53.141% |
| Xencor, Inc. | -126.08 Million USD | 6.007% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -3047.169% |
| Replimune Group, Inc. | -215.79 Million USD | 45.08% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -457.275% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 4823.515% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -1678.166% |
| Portage Biotech Inc. | -75.33 Million USD | -57.306% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -1314.771% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -22.614% |
| OncoCyte Corporation | -27.78 Million USD | -326.597% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -783.291% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -965.619% |
| Purple Biotech Ltd. | -19.88 Million USD | -496.142% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -1588.46% |
| scPharmaceuticals Inc. | -54.81 Million USD | -116.225% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -576.98% |
| HilleVax, Inc. | -123.56 Million USD | 4.089% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -1072.583% |
| Tharimmune, Inc. | -9.31 Million USD | -1171.722% |
| Genprex, Inc. | -30.86 Million USD | -284.029% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | 49.767% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -293.809% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -6550.561% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -2137.777% |
| OKYO Pharma Limited | -16.82 Thousand USD | -704267.072% |
| Savara Inc. | -54.69 Million USD | -116.668% |
| Curis, Inc. | -47.41 Million USD | -149.959% |
| Daré Bioscience, Inc. | -30.16 Million USD | -292.929% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -667.318% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -2028.084% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -297.495% |
| BeiGene, Ltd. | -881.7 Million USD | 86.559% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -456.556% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | 72.841% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -50.102% |
| Erasca, Inc. | -125.04 Million USD | 5.221% |
| bluebird bio, Inc. | -211.91 Million USD | 44.075% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -2270.024% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 170.693% |
| DBV Technologies S.A. | -72.72 Million USD | -62.958% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -2270.024% |
| Moderna, Inc. | -4.71 Billion USD | 97.486% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -195.124% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -1981.366% |
| Molecular Templates, Inc. | -8.12 Million USD | -1358.801% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -96.253% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -6.386% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | 12.441% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -147.319% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | 16.203% |
| Cogent Biosciences, Inc. | -192.41 Million USD | 38.406% |
| MacroGenics, Inc. | -9.05 Million USD | -1208.379% |
| RenovoRx, Inc. | -10.23 Million USD | -1058.258% |
| Adicet Bio, Inc. | -142.65 Million USD | 16.925% |
| Prime Medicine, Inc. | -198.13 Million USD | 40.185% |
| Aditxt, Inc. | -32.38 Million USD | -265.997% |
| Adagene Inc. | -18.94 Million USD | -525.518% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -1520.863% |
| Quantum-Si incorporated | -95.96 Million USD | -23.503% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | 0.434% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -712.971% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 189.559% |
| SciSparc Ltd. | -5.12 Million USD | -2213.803% |
| Vericel Corporation | -3.18 Million USD | -3624.481% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -98452.231% |
| Minerva Neurosciences, Inc. | -30 Million USD | -294.973% |
| Generation Bio Co. | -126.61 Million USD | 6.397% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -62.589% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -43.753% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | 54.79% |
| Invivyd, Inc. | -198.64 Million USD | 40.339% |
| Relay Therapeutics, Inc. | -341.97 Million USD | 65.344% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -1264.324% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 619.657% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -1100.253% |
| 2seventy bio, Inc. | -217.57 Million USD | 45.529% |
| ADMA Biologics, Inc. | -28.23 Million USD | -319.678% |
| Clene Inc. | -49.5 Million USD | -139.401% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -431.745% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -139.74% |
| GeoVax Labs, Inc. | -25.96 Million USD | -356.403% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | 63.875% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -264.175% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 621.624% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -19.962% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -58.537% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | 26.3% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 80.732% |
| Evaxion Biotech A/S | -22.12 Million USD | -435.652% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -46.791% |
| Verve Therapeutics, Inc. | -200.06 Million USD | 40.764% |
| Trevena, Inc. | -40.28 Million USD | -194.157% |
| Surrozen, Inc. | -43.04 Million USD | -175.343% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -71.425% |
| Cingulate Inc. | -23.53 Million USD | -403.562% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -1614.598% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -197.323% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -1436.999% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -31.375% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -93.377% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -99.171% |
| Clearmind Medicine Inc. | -11.95 Million USD | -891.323% |
| Kronos Bio, Inc. | -112.67 Million USD | -5.183% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -71.269% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -4672701.757% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -37.974% |
| Statera Biopharma, Inc. | -174.4 Million USD | 32.048% |
| ImmunityBio, Inc. | -583.19 Million USD | 79.679% |
| Korro Bio, Inc. | -81.17 Million USD | -46.002% |
| Kineta, Inc. | -14.09 Million USD | -740.577% |
| BioVie Inc. | -32.12 Million USD | -268.963% |
| Codexis, Inc. | -76.24 Million USD | -55.447% |
| Celularity Inc. | -196.29 Million USD | 39.625% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | 44.757% |
| Celcuity Inc. | -63.77 Million USD | -85.818% |
| Virax Biolabs Group Limited | -6.73 Million USD | -1660.041% |
| Cibus, Inc. | -267.62 Million USD | 55.717% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -193.887% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -230.94% |
| IN8bio, Inc. | -30 Million USD | -294.951% |
| Kodiak Sciences Inc. | -260.49 Million USD | 54.504% |
| Annexon, Inc. | -134.23 Million USD | 11.714% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -1.151% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -93.56% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -275.707% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | 67.645% |
| Eyenovia, Inc. | -27.26 Million USD | -334.733% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 648.9% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -22051.963% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -55.114% |
| Arcellx, Inc. | -70.69 Million USD | -67.652% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -185.98% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | 11.436% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -294.557% |
| Moolec Science SA | -51.78 Million USD | -128.839% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -126.295% |
| Geron Corporation | -184.12 Million USD | 35.635% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -182.349% |
| Royalty Pharma plc | 1.13 Billion USD | 110.443% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | 12.83% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -1232.834% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -457.886% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | 30.965% |
| Humacyte, Inc. | -110.77 Million USD | -6.984% |
| Structure Therapeutics Inc. | -89.62 Million USD | -32.239% |
| 89bio, Inc. | -142.18 Million USD | 16.651% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -71.858% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -1042.074% |
| Genelux Corporation | -28.29 Million USD | -318.818% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -307.752% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | 33.088% |
| Notable Labs, Ltd. | -11.26 Million USD | -952.14% |
| Liquidia Corporation | -78.5 Million USD | -50.968% |
| Mustang Bio, Inc. | -51.6 Million USD | -129.667% |
| Immunovant, Inc. | -259.33 Million USD | 54.301% |
| Quantum-Si incorporated | -95.96 Million USD | -23.503% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -62.683% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -511.491% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -23.464% |
| Acasti Pharma Inc. | -12.85 Million USD | -822.065% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -427.713% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -642.486% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | 35.023% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -2655.144% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -850.385% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -301.862% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -203.973% |
| PepGen Inc. | -78.62 Million USD | -50.73% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -298.109% |
| United Therapeutics Corporation | 984.8 Million USD | 112.034% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -432.403% |
| Solid Biosciences Inc. | -96.01 Million USD | -23.432% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -2373.418% |
| Immuneering Corporation | -53.47 Million USD | -121.637% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -2229.71% |
| Silo Pharma, Inc. | -3.7 Million USD | -3102.463% |
| Belite Bio, Inc | -31.63 Million USD | -274.662% |
| XOMA Corporation | -40.83 Million USD | -190.253% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -117.995% |
| Bionomics Limited | -15.49 Billion USD | 99.235% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -41.112% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -306.465% |
| uniQure N.V. | -308.47 Million USD | 61.581% |
| Cassava Sciences, Inc. | -97.21 Million USD | -21.906% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -1520.863% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | 3.984% |
| Forte Biosciences, Inc. | -31.47 Million USD | -276.519% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -1344.98% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -307.71% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -22051.963% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -351.788% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -618.914% |
| Altimmune, Inc. | -88.44 Million USD | -33.993% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | 21.817% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -306.465% |
| Compugen Ltd. | -18.75 Million USD | -531.935% |
| Peak Bio, Inc. | -1259.26 USD | -9411220.935% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -157.363% |
| Benitec Biopharma Inc. | -21.75 Million USD | -444.862% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | 65.019% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -42.866% |
| Zura Bio Limited | -60.36 Million USD | -96.344% |
| PolyPid Ltd. | -23.86 Million USD | -396.598% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -653.324% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -42.866% |
| Instil Bio, Inc. | -156.08 Million USD | 24.072% |
| argenx SE | -295.05 Million USD | 59.833% |
| Immunome, Inc. | -106.8 Million USD | -10.961% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -178.893% |
| Verona Pharma plc | -54.36 Million USD | -117.979% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -18.611% |
| Shattuck Labs, Inc. | -87.29 Million USD | -35.757% |
| CervoMed Inc. | -2.17 Million USD | -5356.719% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | 4.924% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -790.005% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -172.1% |
| Moolec Science SA | -51.78 Million USD | -128.839% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -685273.875% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | 12.289% |
| AnaptysBio, Inc. | -163.61 Million USD | 27.568% |
| Design Therapeutics, Inc. | -66.86 Million USD | -77.25% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -45.568% |
| NeurAxis, Inc. | -14.62 Million USD | -710.252% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -212.848% |
| Lumos Pharma, Inc. | -34.03 Million USD | -248.219% |
| Achilles Therapeutics plc | -69.66 Million USD | -70.118% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -18.611% |
| 180 Life Sciences Corp. | -19.93 Million USD | -494.494% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 4038.892% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -4672701.757% |
| Nutriband Inc. | -5.48 Million USD | -2060.551% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -17.693% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -143.819% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -53.731% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -248.875% |
| MoonLake Immunotherapeutics | -36 Million USD | -229.136% |
| Palisade Bio, Inc. | -12.3 Million USD | -863.52% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -181.343% |
| Beam Therapeutics Inc. | -132.52 Million USD | 10.574% |
| Neurogene Inc. | -36.31 Million USD | -226.329% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | 27.477% |
| AEON Biopharma, Inc. | -52.55 Million USD | -125.499% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -20.751% |
| Sesen Bio, Inc. | -19.88 Million USD | -496.022% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -65.558% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -847.051% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | 73.31% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -6.227% |
| Athira Pharma, Inc. | -117.67 Million USD | -0.715% |
| Vaccinex, Inc. | -20.25 Million USD | -485.22% |
| HCW Biologics Inc. | -24.99 Million USD | -374.161% |
| XOMA Corporation | -40.83 Million USD | -190.253% |
| Nektar Therapeutics | -276.05 Million USD | 57.069% |
| Arvinas, Inc. | -367.3 Million USD | 67.734% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -175931.192% |
| Merus N.V. | -154.93 Million USD | 23.51% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -21.642% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -277.61% |
| Rezolute, Inc. | -68.45 Million USD | -73.115% |
| Clene Inc. | -49.5 Million USD | -139.401% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -668.394% |
| BeyondSpring Inc. | -21.02 Million USD | -463.65% |
| Synlogic, Inc. | -57.28 Million USD | -106.894% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -895.824% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -994.707% |
| Peak Bio, Inc. | -1259.26 USD | -9411220.935% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -217.151% |
| Krystal Biotech, Inc. | 10.93 Million USD | 1184.093% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | 17.181% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | 63.546% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -2465.791% |
| MannKind Corporation | -11.93 Million USD | -892.737% |
| Ikena Oncology, Inc. | -68.16 Million USD | -73.859% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -463.945% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -27.525% |
| Gossamer Bio, Inc. | -179.81 Million USD | 34.092% |
| CohBar, Inc. | -11.96 Million USD | -890.736% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -359.566% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -293.078% |
| Legend Biotech Corporation | -518.25 Million USD | 77.132% |
| Mural Oncology plc | -207.44 Million USD | 42.871% |
| Biora Therapeutics, Inc. | -124.11 Million USD | 4.514% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -547.976% |
| Disc Medicine, Inc. | -76.42 Million USD | -55.063% |
| Champions Oncology, Inc. | -7.27 Million USD | -1528.821% |
| REGENXBIO Inc. | -263.49 Million USD | 55.023% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -1016.67% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -149.475% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -212.012% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -18.32% |
| Vaxart, Inc. | -82.46 Million USD | -43.713% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 35608.13% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -215.677% |
| Cellectis S.A. | -101.05 Million USD | -17.271% |
| Longeveron Inc. | -21.41 Million USD | -453.463% |
| Repare Therapeutics Inc. | -93.79 Million USD | -26.352% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 77.888% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -66.523% |
| Revolution Medicines, Inc. | -436.36 Million USD | 72.841% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -1703.576% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -284.483% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -70.933% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -83.083% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -1107.96% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 103.274% |
| Denali Therapeutics Inc. | -145.22 Million USD | 18.393% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -98452.231% |
| Veru Inc. | -93.15 Million USD | -27.224% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -338.466% |
| Cingulate Inc. | -23.53 Million USD | -403.562% |
| Passage Bio, Inc. | -102.06 Million USD | -16.119% |
| Context Therapeutics Inc. | -23.96 Million USD | -394.542% |
| Exicure, Inc. | -16.91 Million USD | -600.68% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | 37.267% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -213.825% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -1721.225% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | 35.827% |
| Nuvalent, Inc. | -126.21 Million USD | 6.105% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -1027.015% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -36.412% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -288.007% |
| OmniAb, Inc. | -50.61 Million USD | -134.128% |
| Anew Medical, Inc. | 1.34 Million USD | 8904.012% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -638.629% |
| Lipocine Inc. | -16.35 Million USD | -624.758% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -78.5% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -86.122% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -180.878% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -147.072% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -497.615% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 78.113% |
| Ocugen, Inc. | -63.07 Million USD | -87.883% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -23.797% |
| Q32 Bio Inc. | -112.96 Million USD | -4.915% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -589.35% |
| Alumis Inc. Common Stock | -154.99 Million USD | 23.537% |
| Equillium, Inc. | -13.33 Million USD | -788.736% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -96.324% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -1383.668% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -528.675% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -100.591% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -3.48% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -544.865% |
| Dominari Holdings Inc. | -22.88 Million USD | -417.931% |
| Edesa Biotech, Inc. | -8.37 Million USD | -1315.179% |
| vTv Therapeutics Inc. | -20.25 Million USD | -485.249% |
| Bio-Techne Corporation | 168.1 Million USD | 170.499% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | 66.34% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 191.975% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | 2.724% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -212.378% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -5.212% |
| Nkarta, Inc. | -117.5 Million USD | -0.861% |
| BioCardia, Inc. | -11.57 Million USD | -924.224% |
| Iterum Therapeutics plc | -38.37 Million USD | -208.861% |